Regeneron Pharmaceuticals (REGN) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $20.07
- Estimate
- $16.25
- Surprise
- +23.5%
- Revenue (period 2026-09-30)
- $5.12B
- Score at report (before → after)
- 6.0 → 5.9/10
Revenue source: xbrl.
How the report landed
Regeneron Pharmaceuticals (REGN) beat the $16.25 estimate with adjusted EPS of $20.07 — a large 23.5% upside surprise. TrendMatrix's engine moved from Buy (Wait) (6.0/10) to Hold at 5.9/10 after the report — the engine's score fell despite the beat.
Where TrendMatrix's rating stands now
TrendMatrix currently rates REGN Hold at 5.9/10.
4 of the last 4 quarters beat the estimate; this quarter's +23.5% surprise compares with a +19.1% four-quarter average.
What supports the rating
- V7 quality resilience bonus: +0.2 (Q=7.3 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Analyst target reached - limited upside remaining
- Near 52-week high (0.8% away)
- Weak growth
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $927.89
- Stop
- $872.61
The stock trades at 23.2× trailing but 14.8× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 83 — a level conventionally read as overbought; gains at these levels often lean on momentum; trading volume is running 3.9× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-10-31 — shown for context, not personalized investment advice.
REGN at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Biotechnology
- Market cap
- $95.53B
- P/E (fwd)
- 14.8
- P/E (ttm)
- 23.2
- 52-week range
- $591.52–$935.35
- Off 52-week high
- 0.8%
- RSI (14)
- 83
- Volume vs avg
- 3.85×
- Score today
- 5.9/10